Founders Capital Management (Texas)’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,000
Closed -$12.1K 387
2025
Q1
$12.1K Hold
2,000
0.01% 261
2024
Q4
$7.9K Hold
2,000
0.01% 289
2024
Q3
$11.7K Hold
2,000
0.01% 274
2024
Q2
$8.62K Hold
2,000
0.01% 289
2024
Q1
$9.4K Hold
2,000
0.01% 292
2023
Q4
$9.82K Sell
2,000
-1,000
-33% -$4.9K 0.01% 292
2023
Q3
$16.4K Buy
3,000
+500
+20% +$4.01K 0.01% 244
2023
Q2
$23.1K Buy
2,500
+1,000
+67% +$8.46K 0.02% 222
2023
Q1
$12K Buy
1,500
+500
+50% +$5.52K 0.01% 299
2022
Q4
$11K Hold
1,000
0.01% 295
2022
Q3
$12K Hold
1,000
0.01% 278
2022
Q2
$15K Hold
1,000
0.01% 263
2022
Q1
$24K Hold
1,000
0.02% 193
2021
Q4
$24K Hold
1,000
0.02% 193
2021
Q3
$20K Buy
+1,000
New +$20.5K 0.01% 216

Other funds holding MPT

Founders Capital Management (Texas)'s MPT Position: Q2 2025 in Review

Founders Capital Management (Texas) sold out of Medical Properties Trust (MPT) in Q2 2025, closing a stake of 2,000 shares — an estimated $12.1K sold.

Founders Capital Management (Texas) first reported a position in MPT in Q3 2021 and held it in 15 quarters. The position peaked at $24K in Q1 2022. 475 funds tracked by Wall St. Rank hold MPT as of Q2 2025.

  • Founders Capital Management (Texas) reported no remaining Medical Properties Trust position as of Q2 2025 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 2,000 Medical Properties Trust shares in Q2 2025, an estimated $12.1K.
  • Founders Capital Management (Texas) first reported a position in Medical Properties Trust in Q3 2021 and held it in 15 quarters.
  • Founders Capital Management (Texas)'s Medical Properties Trust position peaked at $24K in Q1 2022.
  • 475 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2025.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2025, filed 18 Jul 2025.